Full Text View
Tabular View
No Study Results Posted
Related Studies
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
This study is ongoing, but not recruiting participants.
Study NCT00054691   Information provided by M.D. Anderson Cancer Center
First Received: February 6, 2003   Last Updated: August 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Skin Cancer
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Basal Cell
Carcinoma, Basosquamous
Carcinoma, Squamous Cell
Skin Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Basal Cell
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Skin Diseases
Interventions listed in this trial
Iressa
Additional drug interventions recognized in this trial
Gefitinib
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services